I don't know much about medical research, but I've looked into some of these trials. They are generally being done by startups and not the established players w

I don't know much about medical research, but I've looked into some of these trials. They are generally being done by startups and not the established players who sell the diabetes management stuff. So think disruptive tech. A new player comes into the market with something that obsoletes the old tech, and maybe destroys a whole market. But that new player makes their own money off it. So yeah, maybe Tandem, Dexcom and Medtronic don't have a big incentive. But someone else can make some real money if they can find a cure or novel treatment that obsoletes all those others things.